Dashboard

Thursday, March 27, 2026
Back to site
Revenue Today
$3,240
18% vs last Thu
Appointments Today
14
3 remaining
New Clients This Week
7
40%
Membership Revenue
$8,970
MTD
Today's Appointments
View Full Schedule
Time Client Service Provider Status
9:00 AM Sarah Johnson Botox (20 units) Dr. Sarah Checked In
9:30 AM Michelle Torres HydraFacial Maria Checked In
10:00 AM Jennifer Lee Dermal Fillers Dr. Sarah In Progress
10:30 AM Amanda Clark IV Hydration Maria Confirmed
11:00 AM Rachel Kim Microneedling Dr. Sarah Confirmed
12:00 PM Lisa Wang Weight Loss Consult Dr. Sarah Scheduled
1:30 PM Brittany Hayes Chemical Peel Maria Scheduled
2:00 PM Karen Mitchell Lip Filler Dr. Sarah Scheduled
3:00 PM Diana Ross LED + HydraFacial Maria Scheduled
4:00 PM Stephanie Cruz Botox Touch-up Dr. Sarah Scheduled
AI Insights
Botox bookings up 23% this month compared to February. Your Tuesday afternoon slots fill fastest.
12 clients requested Saturday PM slots this week. Consider adding Saturday afternoon hours to capture this demand.
Membership conversion opportunity: 8 repeat clients haven't enrolled in a plan yet. A targeted email could convert 3-4 into $299/mo members.
Ardonis Capital — Financial Overview
Open Full Accounting →
Revenue MTD $47,250
Expenses MTD $18,400
Net Profit $28,850
Outstanding Invoices 3 ($2,175)
Payroll This Period $12,500
Invoice Client Amount Status
INV-0042 Sarah Johnson $650 Paid
INV-0043 Jennifer Lee $875 Pending
INV-0044 Michelle Torres $650 Overdue
AI Research Assistant
View All Reports →
GLP-1 medication trends Non-invasive body contouring 2026 Med spa customer retention Botox vs Dysport efficacy

Semaglutide vs Tirzepatide: 2025-2026 Comparative Analysis

Key Findings

Tirzepatide shows 22.5% average weight loss vs 15% for semaglutide in head-to-head trials (SURMOUNT-5, 2025). Tirzepatide's dual GIP/GLP-1 mechanism provides superior glycemic control.

Clinical Implications

Consider offering both options. Tirzepatide commands higher pricing ($499/mo vs $399/mo) with stronger efficacy data to justify the premium.

Sources: SURMOUNT-5 Trial (NEJM, 2025), FDA Prescribing Information, American Society of Bariatric Physicians Guidelines 2026

Staff On Duty
SC
Dr. Sarah Chen
Injector
6 appointments
On Shift
MG
Maria Gonzalez
Esthetician
4 appointments
On Shift
JT
Jessica Taylor
Front Desk
On Shift
B
Brett
Owner
Admin